PUBLICATION
Loss of carbohydrate sulfotransferase 6 function leads to macular corneal dystrophy phenotypes and skeletal defects in zebrafish
- Authors
- Basol, M., Ersoz-Gulseven, E., Ozaktas, H., Kalyoncu, S., Utine, C.A., Cakan-Akdogan, G.
- ID
- ZDB-PUB-241207-2
- Date
- 2024
- Source
- The FEBS journal 292(2): 373-390 (Journal)
- Registered Authors
- Basol, Merve, Cakan-Akdogan, Gülcin, Özaktaş, Helin
- Keywords
- CRISPR/Cas9, carbohydrate sulfotransferase 6, keratan sulfate proteoglycan, macular corneal dystrophy, zebrafish
- MeSH Terms
-
- Gene Editing
- Carbohydrate Sulfotransferases*
- Animals
- Humans
- Zebrafish Proteins*/genetics
- Zebrafish Proteins*/metabolism
- Sulfotransferases*/genetics
- Sulfotransferases*/metabolism
- CRISPR-Cas Systems
- Cornea/metabolism
- Cornea/pathology
- Keratan Sulfate/genetics
- Keratan Sulfate/metabolism
- Disease Models, Animal*
- Zebrafish*/genetics
- Phenotype*
- Corneal Dystrophies, Hereditary*/genetics
- Corneal Dystrophies, Hereditary*/metabolism
- Corneal Dystrophies, Hereditary*/pathology
- PubMed
- 39642091 Full text @ FEBS J.
Citation
Basol, M., Ersoz-Gulseven, E., Ozaktas, H., Kalyoncu, S., Utine, C.A., Cakan-Akdogan, G. (2024) Loss of carbohydrate sulfotransferase 6 function leads to macular corneal dystrophy phenotypes and skeletal defects in zebrafish. The FEBS journal. 292(2):373-390.
Abstract
The carbohydrate sulfotransferase 6 (chst6) gene is linked to macular corneal dystrophy (MCD), a rare disease that leads to bilateral blindness due to the accumulation of opaque aggregates in the corneal stroma. chst6 encodes for a keratan sulfate proteoglycan (KSPG) specific sulfotransferase. MCD patients lose sulfated KSPGs (cKS) in the cornea and the serum. The significance of serum cKS loss has not been understood. Zebrafish cornea structure is similar to that of humans and it contains high levels of sulfated cKS in the stroma. Here, zebrafish chst6 is shown to be expressed in the cornea and head structures of the embryos. An animal model of MCD is developed by generating chst6 mutant animals with CRISPR/Cas9-mediated gene editing. The dramatic decrease in cKS epitopes in the mutants was shown with ELISA and immunofluorescence. Morphological defects or alterations of jaw cartilage were detected in a minor fraction of the mutant larvae. Loss of cKS epitopes and morphological defects was fully rescued with wild-type chst6. Mutant adult zebrafish displayed all clinical manifestations of MCD, while a fraction also displayed jaw and skeleton defects. Opaque accumulations formed in the eye, which were alcian blue positive. Loss of cKS in the corneal stroma and a decrease in corneal thickness were shown. Interestingly, alteration of transforming growth factor beta-induced (BIGH3) expression which was not described in patients was also observed. This is the first report of an MCD model in a genetically tractable organism, providing a preclinical model and insight into the importance of KSPG sulfation for proper skeletal morphogenesis.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping